Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Pedro.
Nice looking back and reading your last note on 19th Jan after a previous ST note.
I do always think "this really does now look cheap, if they can get to £20m and then show growth potential beyond this..." But with this bod it just goes lower.
I think the recent rise is more a relief rally, but as I have said before the full accounts will be a test rather than the "highlights" of an rns. The other issue is I still have zero trust in the bod providing their view of the £ value of an order, these have proved wildly inaccurate in the past.
I do hope to see signs the new chair and cfo are running the company rather than the ceo who really should be in a lab coat.
In June 21 Kromek were awarded a 28 month contract to develop the pathogen detection system for DARPA.
This is due to end around December 23 and if delivered to that timescale is a game changer. All signs on track but we will see when the results are announced. In the meantime stars are aligning for the core parts of the business and we need some more material contracts in 2022 to move forward. A major bit of comfort was the strong cash position in the last update which I think is driving a bit more confidence. I agree a rally to 14p could well be the limit ahead of a confidence booster IMHO DYOR
You’d be better off at the casino on red and black. At least that way you won’t be giving your capital interest free for 1-3years. Essentially nothing the board can be trusted. Don’t you think it’s odd that they have this ground breaking biological pathogen detector technology, yet there is no government or media interest? A bit odd if there wasn’t the track record of Kromek. With the track record of Kromek it’s completely believable. Who knows. But past performance is probably a good indication of what the future holds - and that future is a golden turd freshly laid by the CEO who is adamant it’s not a turd but a superb golden egg
This should never have dropped below .40p in my opinion.
Great value growth share....now at the right place.....at the right time.....the geo political situation will propel this share going forward.....this should be 40p...in my opinion....
Thanks skid35 you put my very basic/honest comments into context in a very clear way.
Let's just look at a few of the issues with the ST article.
- "Estimated contract backlog" - what the hells that - it's either contracted or its not - as we know with KMK this is pretty much a made up number. if you haven't got contracted backlog you cannot account for that amount as a contract.
- There is czt and there is czt, KMK being the pound shop compared to redlan. You have to ask why didn't Canon buy KMK at a fraction of the price.
- Nothing on the operational miss, after stating everything was under control.
- Add the miss back into this year, take it off next and growth is nothing.
- I expect the takeaway from the annual report will be a complete write off of the AROC balances, they clearly haven't recovered any of this money. Bound to be another dodgy accounting gem in there somewhere in the notes.
- News void from my last write up...from the one before....from the one befor..from when the price has halved and is now a small percentage of my target - has all the narcissism as bozo.
Good news is the hopeless ex cfo is still underwater, although basu probably gave him a 20 year option period.
Sadly those who trust Simon T will join those who followed Questor buying into this outfit. "Welcome" to Smoke and Mirrors PLC...Do not worry too much ,it is only money you are losing. Your health is much more important.
https://www.kromek.com/news/rethinking-our-readiness-whitepaper-authored-by-experts-in-the-field/
Simon Thomson's bargain shares portfolio 2022
https://metsoa.com/bargain-shares-winners-in-an-uncertain-world/
I see he is forecasting a 48% rise in revenue to £18m and cash profitability going forward. I would hope for a lot more than this !!
Just been tipped yet again by Simon Thompson